Products from the last 3 months
| Axon ID | Name | Description | From price | |
|---|---|---|---|---|
| 3000 | ABX-1431 | Highly potent, selective, brain-penetrant, and orally available MAGL inhibitor | Recently added | €135.00 |
| 2948 | AM 580 | RAR-α agonist | Recently added | €95.00 |
| 3015 | Amlodipine besylate | Ca2+ channel blocker | Recently added | €90.00 |
| 2819 | APX-115 | First-in-class pan-NADPH oxidase (Nox) inhibitor | Recently added | €125.00 |
| 3013 | Aranidipine | Ca2+ channel antagonist | Recently added | €110.00 |
| 2960 | ATR-101 | Potent, selective, and orally active ACAT1 inhibitor | Recently added | €145.00 |
| 2957 | BACE-2 Inhibitor | Potent and highly selective BACE 2 inhibitor | Recently added | €135.00 |
| 3014 | Barnidipine hydrochloride | Potent Ca2+ channel blocker (L-type voltage gated) | Recently added | €105.00 |
| 2964 | CD12681 | Potent RORγ inverse agonist | Recently added | €135.00 |
| 2916 | Cevipabulin | Potent microtubule-active antitumor agent | Recently added | €140.00 |
| 3011 | DMNQ | Redox cycling agent | Recently added | €95.00 |
| 2788 | ER-819762 | Highly selective, and orally available PGE2 receptor EP4 antagonist | Recently added | €155.00 |
| 2959 | FM19G11 | Potent HIFα inhibitor | Recently added | €95.00 |
| 3006 | GKT137831 | First-in-class dual NADPH oxidase (Nox) 1/4 inhibitor | Recently added | €95.00 |
| 3007 | GSK 8612 | Potent and highly selective TBK1 inhibitor | Recently added | €120.00 |